AMBER DEPAOLA: Open Payments
NPI 1003540915 · EAST GREENWICH, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 61 payments from 18 companies in 2025. Trend: 2023 $869 · 2024 $972 · 2025 $1,275
Food & beverage: $1,275
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $270 |
| AstraZeneca Pharmaceuticals LP | 9 | $193 |
| GlaxoSmithKline, LLC. | 7 | $133 |
| Novo Nordisk Inc | 5 | $129 |
| PFIZER INC. | 4 | $86 |
| Inspire Medical Systems, Inc. | 3 | $57 |
| Amgen Inc. | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 1 | $50 |
| Abbott Laboratories | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
Products named: UBRELVY, TRELEGY ELLIPTA, Wegovy, QULIPTA, NURTEC ODT, INSPIRE, VOQUEZNA, REXULTI.
Industry payments across RI — which companies pay providers there.
